Home > Healthcare > Biotechnology > Biotechnology R&D > Cell Lysis & Disruption Market
Cell Lysis & Disruption Market size was valued USD 5.1 billion in 2023 and is expected to reach USD 10.9 billion by 2032 growing at a CAGR of 8.6% over the analysis period. High growth can be attributed to the expanding biopharmaceutical industry that relies on cell lysis and disruption techniques to produce therapeutic proteins, monoclonal antibodies, and vaccines.
Also, the growing interest in precision medicine and advancements in genomics research has further increased the demand for cell lysis and disruption technologies. Moreover, growing investments by several organizations, including government and private, towards the research and development related to biotechnological processes are further expected to drive the market. Thus, as the life sciences industry continues to evolve, the cell lysis and disruption market are expected to witness sustained growth.
Cell lysis and disruption refer to the process of breaking open or disrupting the cell membrane of biological cells, releasing the cellular contents. This is a crucial step in various biological and biochemical applications, such as protein purification & isolation, DNA or RNA isolation, and the production of cellular products.
Report Attribute | Details |
---|---|
Base Year: | 2023 |
Cell Lysis & Disruption Market Size in 2023: | USD 5.1 Billion |
Forecast Period: | 2024 to 2032 |
Forecast Period 2024 to 2032 CAGR: | 8.6% |
2032 Value Projection: | USD 10.9 Billion |
Historical Data for: | 2018 to 2023 |
No. of Pages: | 250 |
Tables, Charts & Figures: | 532 |
Segments covered: | Technique, Product, Cell Type, Application, End-use, & Region |
Growth Drivers: |
|
Pitfalls & Challenges: |
|